関連する実験動画
Updated: Sep 9, 2025
03:52
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
Published on: February 21, 2025
498
サルコペニアのリスクとサルコペニーの全因死亡におけるメチルマロン酸の役割:NHANESからの証拠
Ping Zhu1, Jie Zhang2, Xue-Chun Liu1,3
1State Key Laboratory for Innovation and Transformation of Luobing Theory; Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences; Department of Cardiology Qilu Hospital of Shandong University Jinan China.
Food science & nutrition
|September 5, 2025
まとめ
メチルマロン酸 (MMA) の増加は筋肉質の低下を予測し,死亡リスクを増やす. MMAを減らすことは,サルコーペニアの進行を緩和し,予後を改善するのに役立ちます.
科学分野:
- ゲロントロジー
- 代謝医学
- ミトコンドリア生物学
背景:
- ミトコンドリア機能障害は,サルコペニアの発症と結果の重要な要因です.
- 筋肉質はサルコペニアを定義する上で重要な要素です.
- メチルマロン酸 (MMA) はミトコンドリア機能障害とB12欠乏症のバイオマーカーです.
研究 の 目的:
- 低筋量およびサルコペニアにおけるMMAの予測および予後効果を調査する.
- MMA濃度と低筋肉の発生率との関連を分析する.
- アメリカの大人の集団におけるMMAと全因死亡率の関係を評価する.
主な方法:
- 米国国民健康栄養調査から 10,414人の成人を対象とした分析.
- 低筋量発生のロジスティック回帰,死亡率のコックス回帰とカプラン・マイヤー回帰.
- 制限された立方スプライン (RCS) を用いて,MMAと死亡率の投与量-反応関係をモデル化.
主要な成果:
- 調整後,独立して予測された低筋肉量 (OR=1. 30) と全因死亡率 (HR=2.17) のMMA上昇.
- RCSは,MMA濃度の上昇とともに単調な死亡率の増加を示した (p<0. 001).
- 特に筋肉質が低い高齢者において,MMA三角動物における死亡率の有意な差異 (ログランクp<0. 001).
結論:
- 血清MMAは,低筋肉の発生率と死亡率を予測するための二重のバイオマーカーです.
- 発見は,サルコーペニアの早期リスク検出と予後分層化におけるMMAの臨床的有用性を支持する.
- サルコペニアの病原性に対処し,結果を改善するために,MMAの減少を標的としたさらなる研究が必要である.
さらに関連する動画
関連する概念動画
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
01:25Role of Vitamins in Maintaining Bone Health
3.6K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
3.6K
01:21Overview of Protein Metabolism
1.8K
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
1.8K
01:37Mitochondria
14.8K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
14.8K
01:29Bone Disorders
3.9K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.9K
01:17Phase II Reactions: Methylation Reactions
335
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
335